Drug Type Therapeutic vaccine |
Synonyms LCMV based vectors (artLCMV) encoding the tumor-associated antigens gp70 |
Target |
Mechanism E2 modulators(Hepatitis C virus E2 glycoprotein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | AT | 08 Apr 2022 |